Telendo is among the 17 deeptech startups selected by EIT Health in May 2025 to join its Venture Builder program, dedicated to accelerating research-driven health technologies across Europe.
A program dedicated to industrializing deeptech innovations in healthcare
Launched by EIT Health, one of Europe’s leading health innovation networks, the Venture Builder program supports high-potential deeptech projects that often struggle to bridge the gap between academic proof of concept and market entry. This stage, frequently described as the “no man’s land” or “valley of death,” slows the valorization of research results and the creation of concrete solutions for patients.
The program provides selected startups with individualized support in:
This selection validates Telendo’s mission to structure visual information in digestive endoscopy to improve diagnosis, patient follow-up, and clinical traceability. After several years of academic research and a technological maturation phase in France, Telendo is now entering a phase of active industrialization.
This European recognition adds to the institutional and clinical support already obtained in France and will accelerate regulatory structuring and the deployment of the solution at the European scale.
